PROTEINAUFREINIGUNG

Patent europeic · EP2598514 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2598514
Numer da la dumonda
EP11736364
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-07-2011
Publitgà
05-06-2013
Concedì
09-09-2020
La protecziun finescha il pli tard
25-07-2031
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 1/18 (2006.01)
C07K 1/36 (2006.01)
C07K 16/24 (2006.01)
Prioritad
GB 201012603 27.07.2010
Dumonda PCT
PCT/EP2011/062837 26.07.2011
Publicaziun PCT
WO2012/013682 02.02.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  4. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  5. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  6. 09-09-2020

    Concedì

    Published in Swissreg on 09.09.2020

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventur

SYMMONS, Jonathan

Berkshire SL1 3WE, GB

WHITCOMBE, Richard

Berkshire SL1 3WE, GB

SPITALI, Mariangela

Berkshire SL1 3WE, GB

PEARCE-HIGGINS, Mark Robert

Berkshire SL1 3WE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.